Obesity drug maker Novo Nordisk posts strong profit …C0NTINUE READING HERE >>>
Novo Nordisk said sales of weight-loss injection Wegovy soared 42 percent in the first nine months of 2024.
Photo: SCOTT OLSON / GETTY IMAGES NORTH AMERICA/Getty Images via AFP/File
Source: AFP
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.
Europe’s most valuable company and the main driver of the Danish economy said it…
>